Search
The Institute of Applied Health Sciences

Professor Sara MacLennan

In this section
Professor Sara MacLennan
Professor Sara MacLennan
Professor Sara MacLennan

PhD CPsychol AFBPsS

Personal Chair

About
Email Address
s.maclennan@abdn.ac.uk
Telephone Number
+44 (0)1224 438125
Office Address

Academic Urology Unit Health Sciences Building (2nd Floor) University of Aberdeen Foresterhill Aberdeen AB25 2ZD

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

I am a psychosocial oncologist and a health psychologist with expertise in qualitative research methodology. I pursue an interdisciplinary approach building multi-stakeholder working in cancer care and have established global partnerships of academics, patients, non-profit organisations, professional organisations and policy makers.

Aberdeen Applied Cancer Research Group (ICANTREAT):

I lead the Aberdeen Applied Cancer Research Group (ICANTREAT)

https://icantreat.org/

The group's research strategy focuses on understanding the impact of cancer and treatment on individual’s lives and methods for involving different stakeholder groups, particularly patients, in the design and delivery of care.

I am Deputy Director of the Academic Urology Unit, Director of Operations for UCAN (Urological CANcer charity) and hold an honorary contract with NHS Grampian. I am an Honorary Research Fellow, Birkbeck University of London. I am a Chartered Psychologist and Associate Fellow of the British Psychological Society, and a registered health psychologist (Health & Care Professions Council).

 

 Current projects include:

Stakeholder engagement in the design and implementation of cancer care:

ICANBE – Managing Fear of Cancer Recurrence

EVOLVE – Giving cancer patients a meaningful voice within the design and delivery of clinical practice guidelines


ICANTREATNEPAL / ICANTREATINDIA – Increasing participation in cancer screening and treatment in India & Nepal (International Global Health Network)

PARTNER –Men’s prostate cancer treatment preferences


OPTIMA – Optimal treatments for patients with solid tumours in Europe through AI

PIONEER – Enhancing prostate cancer diagnosis and treatment through the power of big data in Europe

Example of Impact:

 

 I am to keen to supervise PhD students interested in working in cancer survivorship and supportive care.

Memberships and Affiliations

Internal Memberships

University Committees:

Chair - Institute of Applied Health Sciences (IAHS) Research Strategy Group
Chair - Institute of Applied Health Sciences (IAHS) Health, Safety & Well-being Committee

 

External Memberships

Current External Membership:

Member - European Cancer Organisation Steering Committee for Survivorship and Quality of Life (2021 onwards)
Member - European Cancer Organisation Survivorship Focused Topic Network (2021 onwards)
Member - European Cancer Organisation Workforce Focused Topic Network (2021 onwards)
Member – Executive Committee, British Psychosocial Oncology Society (2016 - onwards)
Member – National Cancer Research Institute –Living With and Beyond Cancer Late Effects Workstream (2019 onwards)
Member – Patient Advocacy Group, European Association of Urologists (2018 - onwards)
Member – Breast Cancer Now, Grants Award Committee (2018 – onwards)
Member – ESRC Peer Review College (2017 – onwards)

Previous External Membership:

Member – MRC Strategic Skills Panel (2013 - 2017)
Member – Grants Award Panel, Carnegie Trust
Member – Executive Committee, Division of Health Psychology Scotland (2016 - 2017)
External Examiner (MSc) MSc Health Psychology, University of Westminster (2008 - 2011)
Member - BPS working party on ‘Work and Health’
Elected Member – Training Committee, Division of Health Psychology (2006 - 2008)
Elected Member - Executive Committee, Division of Health Psychology (2006 – 2008)
Assessor - Board of Assessors, Division of Health Psychology (2002 - 2008)
Examiner – Paper 4 (Health Psychology), Qualifying Examination (2002 – 2012)
Member - BPS working party on ‘Psychological Debriefing’(2001 - 2002)

Latest Publications

  • CATHETER II: a randomised controlled trial comparing the clinical and cost effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long term catheters

    Abdel-Fattah, M., Omar, M. I., Johnson, D., Cooper, D., Constable, L., Tripathee, S., MacLennan, S., Dimitropoulos, K., Evans, S., Granitsiotis, P., Hashim, H., Kilonzo, M., Larcombe, J., Little, P., Murchie, P., Myint, P. K., N'Dow, J., Paterson, C., Powell, K., Scotland, G., Thiruchelvam, N., Young, A. J., Cotton, S., Norrie, J., MacLennan, G.
    BMJ Open, vol. 14, no. 12, e087203
    Contributions to Journals: Articles

  • Web-based interventions for fear of cancer recurrence: a scoping review with a focus on suggestions for the development and evaluation of future interventions

    Zibaite, S., Tripathee, S., Moffat, H., Elsberger, B., MacLennan, S.
    PloS ONE, vol. 19, no. 11, e0312769
    Contributions to Journals: Articles

  • Patient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial

    Tripathee, S., Johnson, D., Constable, L., Cotton, S., Omar, M. I., Abdel-Fattah, M., MacLennan, S.
    RCOG World Congress 2024
    Contributions to Conferences: Posters

  • Patient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial

    Tripathee, S., Johnson, D., Constable, L., Cotton, S., Omar, M. I., Abdel-Fattah, M., MacLennan, S.
    The International Continence Society
    Contributions to Conferences: Posters

  • RCT comparing the clinical and cost effectiveness of various catheter washout policies

    Abdel-Fattah, M., Omar, M. I., Johnson, D., Cooper, D., Constable, L., Tripathee, S., MacLennan, S., Cotton, S., Norrie, J., MacLennan, G., Team, C. I.
    RCOG World Congress 2024
    Contributions to Conferences: Posters

View My Publications

Research

Research Overview

I am a psychosocial oncologist and a health psychologist with expertise in qualitative research methodology. I pursue an interdisciplinary approach building multi-stakeholder working in cancer care and have established global partnerships of academics, patients, non-profit organisations, professional organisations and policy makers. Key to this is an understanding of processes within the delivery of routine clinical care. My research expertise includes process evaluation.

My research strategy focuses on understanding the impact of cancer and treatment on individual’s lives and methods for involving different stakeholder groups, particularly patients, in the design and delivery of care.

 

Research Areas

Applied Health Sciences

View Research Area

Nutrition and Health

View Research Area

Psychology

View Research Area

Research Specialisms

  • Health and Social Care
  • Applied Psychology
  • Health Psychology
  • Oncology

Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.

Current Research

I currently have eleven funded projects (total awards £5,644,624) across three themes:

Stakeholder engagement in the design and implementation of cancer care (Developed and Lead Projects):

  1. ICANBE – Fear of Cancer Recurrence
  2. EVOLVE – Giving cancer patient’s a meaningful voice within the design and delivery of clinical practice guidelines across Europe
  3. PIONEER – Enhancing prostate cancer diagnosis and treatment through the power of big data in Europe; €12,000,000 EU grant (Lead for Aberdeen)
  4. ICANTREAT – Increasing participation in breast cancer screening and treatment in Nepal and in Uganda; screening and treatment inequalities in India (International Global Health Research Group)

 

The design and implementation of better cancer care (Co-applicant):

  1. OPTIMA – Optimal treatments for patients with solid tumours in Europe through AI
  2. PARTNER – Men’s prostate cancer treatment preferences
  3. ICAN – Improving understanding of Urological cancer (Cancer Research Group)
  4. RCOS – Kidney Cancer core outcome set

 

The design and delivery of care and after care - Urology and other long-term conditions (Co-applicant)

  1. SIMS LTFU – Surgical management of female stress urinary incontinence
  2. CATHETER II – Understanding the patient experience of care; embedded qualitative study within a clinical trial to look at Catheter washout policies
  3. PACFIND – Patient-centred care for Fibromyalgia

Funding and Grants

£1,185,670 Arthritis UK (2019 – 2024). Patient-centred Care for Fibromyalgia: New pathway Design (PACFIND). MacFarlane, G [PI], Maclennan SJ et al. [co-applicants]

£24,537 NHS Grampian. (2018-2019). Achieving Self-Directed Integrated Cancer Aftercare (ASICA): developing digitally supported cancer aftercare to achieve high quality, equitable care for diverse populations. Murchie, P [PI], Maclennan SJ et al. [co-applicants]

£9,805 GCRF-IPPF3 (2018). Increasing participation in breast cancer screening and treatment within Manipal, India (CANTREAT). MacLennan, SJ., & Poobalan, A.

£5,341,011 EU IMI (2018-2023). Prostate Cancer Diagnosis and TreatmeNt Enhancement through the Power of Big Data in EuRope – PIONEER (2018 – 2023). PIONEER Consortium – MacLennan SJ – lead applicant for University of Aberdeen group.

£2,271,424 NIHR HTA (2018-2023) Randomised Controlled Trial CompAring THE Clinical And CosT- Effectiveness Of Various Washout Policies Versus No Washout Policy In Preventing Catheter Associated Complications In Adults Living With Long-Term Catheters (CATHETER II Study). Abdel-Fattah, M. [PI], Maclennan SJ et al. [co-applicants]

£175,000 NHS Grampian Endowments (via UCAN) (2018-2021). EVOLVE: Giving Patients a Meaningful Voice in the Design and Delivery of Care. S J MacLennan

£50,000 European Association of Urology (2017-2018). Review of Renal Cell Carcinoma: Muscle-invasive & Metastatic Bladder Cancer (Lymph node Dissection) & Penile Cancer. N’Dow, J., & MacLennan, S.J.

£123,357 UCAN (2017- 2019). Meeting the Needs of Patients: Developing Core outcome Sets for Urological Cancer. MacLennan, S.J.

€1,070    EU COST action STSM-IS1211-35195 (2016). Cancer and Work Participation: Research visit to Dr Angela de Boer, Coronel Institute for Occupational Health, Academic Medical Centre, Amsterdam. MacLennan, SJ.

 £11,548   NHS Grampian Endowments Award (2015 – 2016). Understanding the hard choices made by working women with breast cancer between treatment compliance and working on: clinical vs economic survival. Improving the Role of the NHS in Grampian. MacLennan SJ., Cox T., N’Dow, J & Heys, S.

 £750    Santander Mobility Award (2015), University of Aberdeen. Developing the METIS Collaboration: Cancer Survivorship, Work & Working Life. MacLennan SJ.

 £29,500   ESRC (2014 – 2017) Social Science Perspectives on the Working Lives of Those with Cancer: Psychosocial, Organisational and Economic Perspectives. Cox, T., MacLennan, SJ., Hassard, J., & Brown, H.

 £25,000 Birkbeck University of London (2014) The Metis Collaboration: Cancer Survivorship, Work & Working Life. MacLennan, SJ.

 £109,646    Macmillan Cancer Support (2013 – 2015) Cancer Survivorship: The Patient Journey, Work & Working Life.   MacLennan, SJ., Cox, T., & N’Dow, J.

 £1,426,755  Health Technology Assessment Programme (HTA) (2013 – 2017)Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. (McClinton,S., N’Dow, J., MacLennan, GS., Kilonzo, M., Keeley, F., Anson, K., Clark, C., Pickard, R., Norrie, J., MacLennan, SJ., Thomas, R., Starr, K., Burgess, N., Lam, T., Kurban, L.)

£292,253  Health Technology Assessment Programme (HTA) (2012 – 2015) Ablative therapy for men with localised prostate cancer (Ramsay, C., Pickard, R., Vale, L., Lam, T., Mowatt, G., MacLennan, SJ., Rushton, S., N’Dow, J., Merseburger, A., Shirley, M., & Heidenreich, A. )

 £176,903 Cancer Research Aberdeen & North East Scotland (CRANES) (2012 – 2015) Development of core outcomes for surgical management of localised prostate cancer to support decision-making by patients, clinicians and policy makers (Lam, T., N’Dow, J., MacLennan, SJ., Ramsay, C., & Campbell, M)

£24,680 The Prostate Cancer Charity Scotland (2011 – 2012) Support groups for men who have prostate cancer, their families and friends: identifying best practice models (MacLennan, SJ., Skea, Z, N’Dow, J & McCann, S)

£14,042 Scottish Cancer Research Network (2011 – 2012) Information for choice in urological cancer: What people need, prefer and use (MacLennan, SJ., & Skea, Z)

£10,317 Scottish Cancer Research Network (2010 – 2011) Delivering Peer Support Interventions in Urological Cancer (Employing a research nurse) (MacLennan, SJ., & N’Dow, J)

£150,700UCAN (Urological Cancer Charity) (2008 – 2013) Addressing the gaps in evidence for treatment of urological cancers (Employing a systematic reviewer) (N’Dow, J., MacLennan, SJ., & Imamura, M)

£165,975 The Scottish Government – CSO (2009 – 2012) Postdoctoral Training Fellowship in Health Services and Health of Public Research – The Acceptability and Usefulness of a Trial Participation Decision Aid: A Mixed Methods Study of Patients and Clinicians in the UK (Schumm, K., Campbell, M., Ramsay, C., N’Dow, J., Skea, Z., & MacLennan, SJ)

£245,482 UCAN (Urological Cancer Charity) (2009 – 2013) Information needs of those living with urological cancer (MacLennan, SJ)

£147,000 Macmillan in partnership with UCAN (2009 – 2012) Making life better for those living with urological cancer (MacLennan, SJ)



Datasets

View My Datasets on Pure
Teaching

Courses

Publications

Page 2 of 5 Results 26 to 50 of 124

  • A Systematic Review to Evaluate Patient-Reported Outcomes Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-based Standard for the selection of Health Measurement INstruments (COSMIN) Methodology

    Ratti, M. M., Gandaglia, G., Sisca, E. S., Derevianko, A., Alleva, E., Beyer, K., Moss, C., Barletta, F., Scuderi, S., Omar, M. I., MacLennan, S., Williamson, P. R., Zong, J., MacLennan, S., Mottet, N., Cornford, P., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Brigantic, A.
    Cancers, vol. 14, no. 20, 5120
    Contributions to Journals: Articles

  • An interpretative phenomenological analysis of the meaning of work to women living with breast cancer

    MacLennan, S., Cox, T., Murdoch, S., Eatough, V.
    Chronic Illness, vol. 18, no. 3, pp. 503-516
    Contributions to Journals: Articles

  • Randomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long-term catheters: study protocol for the CATHETER II study

    Abdel-fattah, M., Johnson, D., Constable, L., Thomas, R., Cotton, S., Tripathee, S., Cooper, D., Boran, S., Dimitropoulos, K., Evans, S., Granitsiotis, P., Hashim, H., Kilonzo, M., Larcombe, J., Little, P., MacLennan, S., Murchie, P., Myint, P., N’Dow, J., Norrie, J., Omar, M. I., Paterson, C., Scotland, G., Thiruchelvam, N., MacLennan, G.
    Trials, vol. 23, no. 1, 630
    Contributions to Journals: Articles

  • Secondary Treatment for Men with Localized Prostate Cancer: a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platform

    Beyer, K., Straten, V., Remmers, S., MacLennan, S., Gandaglia, G., Willemse, P. M., Herrera, R., Omar, M. I., Russell, B., Huber, J., Kreuz, M., Asiimwe, A., Abbott, T., Briganti, A., Vanhemelrijck, M., Roobol, M. J., MacLennan, S., The PRIAS Consortium, , The ERSPC Rotterdam Study Group, , The PIONEER Consortium,
    Journal of Personalized Medicine, vol. 12, no. 5, 751
    Contributions to Journals: Articles

  • Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer: an update from the PIONEER Consortium

    Beyer, K., Moris, L., Lardas, M., Omar, M. I., Healey, J., Tripatheed, S., Gandaglia, G., Venderbos, L. D., Vradi, E., van den Broeck, T., Willemse, P. M., Antunes-Lopes, T., Pacheco-Figueiredo, L., Monagas Arteaga, S., Esperto, F., Flaherty, S., Devecseri, Z., Lam, T., Williamson, P. R., Heer, R., Smith, E. J., Asiimwe, A., Huber, J., Roobol, M. J., Zong, J., Mason, M. D., Cornford, P., Mottet, N., MacLennan, S., N'Dow, J., Brigantii, A., MacLennan, S., Van Hemelrijck, M., PIONEER Consortium
    European Urology, vol. 81, no. 5, pp. 503-514
    Contributions to Journals: Articles

  • Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

    Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Molnar, M., Herrera, R., Rauf, A., Campi, R., Greco, I., Shiranov, K., Dabestani, S., van den Broeck, T., Sujenthiran, A., Gacci, M., Gandaglia, G., Omar, M. I., MacLennan, S., Roobol, M. J., Farahmand, B., Vradi, E., Devecseri, Z., Asiimwe, A., Zong, J., MacLennan, S., Collette, L., N'Dow, J., Briganti, A., Bjartell, A., Van Hemelrijck, M., PIONEER Consortium
    BMJ Open, no. 12, e058267
    Contributions to Journals: Articles

  • Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review

    Ratti, M. M., Gandaglia, G., Alleva, E., Leardini, L., Sisca, E. S., Derevianko, A., Furnari, F., Mazzoleni Ferracini, S., Beyer, K., Moss, C., Pellegrino, F., Sorce, G., Barletta, F., Scuderi, S., Omar, M. I., MacLennan, S., Williamson, P. R., Zong, J., MacLennan, S. J., Mottet, N., Cornford, P., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Briganti, A., The PIONEER Consortium
    European Urology Oncology, vol. 5, no. 2, pp. 153-163
    Contributions to Journals: Articles

  • Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT

    Dasgupta, R., Cameron, S., Aucott, L., MacLennan, G., Kilonzo, M. M., Lam, T. B., Thomas, R., Norrie, J., McDonald, A., Anson, K., N'Dow, J., Burgess, N., Clark, C. T., Keeley, F. X., MacLennan, S. J., Starr, K., McClinton, S.
    Health technology assessment (Winchester, England), vol. 26, no. 19, pp. 1-70
    Contributions to Journals: Articles

  • Outcomes of importance to men with advanced prostate cancer:: PIONEER interview study

    Tripathee, S., Healey, J., Beyer, K., Venderbos, L. D., Van Hemelrijck, M., Roobol, M. J., Huber, J., Smith, E. J., Omar, M. I., N'Dow, J., MacLennan, S., MacLennan, S., PIONEER Consortium
    37th Annual Congress of the European Association of Urology, S1550
    Contributions to Journals: Abstracts

  • Patients’ and Health Care Professionals’ Expectations, Experience, and Perception of the Outcomes of Various Washout Policies in Preventing Catheter-associated Complications: Qualitative Study of the CATHETER II

    Tripathee, S., Omar, I., Abdel-Fattah, M., MacLennan, S.
    European Urology Focus, vol. 8, no. 1, pp. 235-238
    Contributions to Journals: Articles

  • Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries

    Giles, R., Maskens, D., Brick, R., Martinez, R., Packer, M., Heng, D., Larkin, J., Bex, A., Jewett, M., Jonasch, E., MacLennan, S. J.
    European Urology Open Science, vol. 37, pp. 3-6
    Contributions to Journals: Articles

  • Work-related Factors in the etiology of Symptoms of Post-traumatic Stress among First Responders: The Brazilian Firefighters Longitudinal Health Study (FLoHS)

    Gomide Vasconcelos, A., de Paula Lima, E., Teoh, K., MacLennan, S. J., Cox, T.
    Cadernos de Saúde Pública/Reports in Public Health, vol. 37, no. 9, e00135920
    Contributions to Journals: Articles

  • EVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY

    Ratti, M. M., Gandaglia, G., Leardini, L., Ferracini, S. M., Sisca, E. S., Derevianko, A., Furnari, S., Beyer, K., Pellegrino, F., Sorce, G., Scuderi, S., Barletta, F., Cucchiara, V., Omar, M. I., Maclennan, S., Zong, J., Maclennan, S. J., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Montorsi, F., Briganti, A.
    Journal of Urology, vol. 206, no. S3, pp. E212-E212
    Contributions to Journals: Abstracts

  • What influences adherence to guidance for post-operative instillation of intravesical chemotherapy to bladder cancer patients?

    Dunsmore, J., Duncan, E., Mariappan, P., de Bruin, M., MacLennan, S., Dimitropoulos, K., Kasivisvanathan, V., Mostafid, H., Briganti, A., N'Dow, J., MacLennan, S.
    BJU International, vol. 128, no. 2, pp. 225-235
    Contributions to Journals: Articles

  • Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial

    Dasgupta, R., Cameron, S., Aucott, L., MacLennan, G., Thomas, R., N'Dow, J., Norrie, J., Anson, K., Keeley Jr, F. X., MacLennan, S., Starr, K., McClinton, S., Kilonzo, M., Lam, T.
    European Urology, vol. 80, no. 1, pp. 46-54
    Contributions to Journals: Articles

  • TISU (Therepeutic Intervention for Stones in the Ureter): ESWL versus Ureteroscopy, a multicentre RCT

    Dasgupta, R., Cameron, S., Aucott, L., Maclennan, G., Thomas, R. E., N'dow, J., Norrie, J., Anson, K., Keeley, F. X., Maclennan, S., Starr, K., Mcclinton, S.
    European Urology, vol. 79, no. S1, pp. S390-S390
    Contributions to Journals: Abstracts

  • Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol

    Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Vradi, E., Gandaglia, G., Omar, M. I., MacLennan, S., Zong, J., Farahmand, B., MacLennan, S. J., Devecseri, Z., Asiimwe, A., Collette, L., Bjartell, A., N'Dow, J., Briganti, A., Van Hemelrijck, M., The PIONEER Consortium
    BMJ Open, vol. 11, no. 2, e040531
    Contributions to Journals: Articles

  • Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and Implementation

    Björkqvist, J., Giles, R. H., Cornford, P., Lydia, M., Van Hemelrijck, M., Darraugh, J., Jane, C., MacLennan, S., MacLennan, S.
    European Urology Focus, vol. 7, no. 5, pp. 947-950
    Contributions to Journals: Articles

  • The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

    Beyer, K., MacLennan, S., Moris, L., Lardas, M., Lardas, M., Mastris, K., Hooker, G., Greene, R., Briers, E., Omar, M. I., Healey, J., Tripathee, S., Gandaglia, G., Venderbos, L. D., Smith, E. J., Bjorkqvist, J., Asiimwe, A., Huberm, J., Roobol, M. J., Zong, J., Bjartell, A., N'Dow, J., Brigantii, A., MacLennan, S., Van Hemelrijck, M., The PIONEER Consortium
    European Urology Focus
    Contributions to Journals: Articles

  • Increasing Engagement for Breast Cancer Screening and Treatment: The "ICANTREAT" Community of Expertise Initiative

    Kathrikolly, T. R., Nair, S., Poobalan, A., Shetty, R. S., Tripathee, S., MacLennan, S. J.
    Asian Pacific Journal of Cancer Prevention, vol. 21, no. 12, pp. 3655-3659
    Contributions to Journals: Articles

  • PIONEER’s systematic review of outcomes in RCTs of men with non-metastatic castration resistant prostate cancer: Is there a need for a core outcome set?

    Beyer, K., MacLennan, S., Lardas, M., Moris, L., Vradi, E., Omar, M. I., MacLennan, S., Briganti, A., Van Hemelrijck, M.
    35th Annual EAU Congress
    Contributions to Conferences: Abstracts

  • Initial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer

    Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Molnar, M., Herrera, R., Rauf, A., Campi, R., Greco, I., Shiranov, K., Dabestani, S., van den Broeck, T., Sujenthiran, A., Gacci, M., Gandaglia, G., Omar, M. I., MacLennan, S., Farahmand, B., Vradi, E., Devecseri, Z., Asiimwe, A., Zong, J., MacLennan, S., Collette, L., N'Dow, J., Briganti, A., Bjartell, A., Van Hemelrijck, M., The PIONEER Consortium
    12th European Multidisciplinary Congress on Urological Cancers 2020
    Contributions to Conferences: Abstracts

  • PIONEER’s operational definitions:: Harmonising clinical characteristics and phenotypes data of prostate cancer patients

    Beyer, K., Moris, L., Lardas, M., Gandaglia, G., Roobol, M. J., Bjartell, A., Omar, M. I., Herrera, R., MacLennan, S., Smith, E. J., Zong, J., Hofmarcher, T., Kermani, N. Z., MacLennan, S., Briganti, A., Reich, C., De Meulder, B., Van Hemelrijck, M.
    12th European Multidisciplinary Congress on Urological Cancers 2020
    Contributions to Conferences: Abstracts

  • Identifying the most appropriate instrument for patient reported outcome measure (PROMS) in patients with clinically localized prostate cancer

    Ratti, M. M., Gandaglia, G., Leardini, L., Mazzoleni, F. S., Sisca, E. S., Derevianko, A., Furnari, F., Beyer, K., Pellegrino, F., Sorce, G., Barletta, F., Scuderi, S., Omar, M. I., MacLennan, S., Zong, J., MacLennan, S., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Briganti, A.
    12th European Multidisciplinary Congress on Urological Cancers 2020
    Contributions to Conferences: Abstracts

  • PIONEER consensus on clinician reported outcome measurements

    Beyer, K., Moris, L., Gandaglia, G., Lardas, M., Healey, J., Omar, M. I., Zong, J., MacLennan, S., Briganti, A., Van Hemelrijck, M., MacLennan, S., The PIONEER Consortium
    12th European Multidisciplinary Congress on Urological Cancers 2020
    Contributions to Conferences: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Working Papers

Update